title: Ergoreflex activity in heart failure.
abstract: A large body of evidence has suggested the existence of a reflex network that becomes hyperactive secondary to musculoskeletal alterations that occur in heart failure (HF) syndrome. Together with sympathoinhibitory cardiovascular reflexes, suppressed in the presence of the syndrome, heart failure can contribute to physical exercise intolerance. The hyperactivation of signals originated from receptors located in skeletal muscles (mechanoreceptors - metaboreceptors) is a recently proposed hypothesis to explain the origin of fatigue and dyspnea symptoms in HF. In HF, other alterations in the reflex control system, which are not mutually exclusive, contribute to dyspnea. The inappropriate stimulation of the arterial baroreceptors, with the consequent lack of inhibition of the muscle metaboreflex and carotid chemoreflex unloading and the increase in the renal vasoconstriction with angiotensin II release can also be considered. Although the functional alterations of the reflexes were used independently to illustrate the sympathetic excitation observed in HF, the interaction between these reflexes under normal and pathological conditions, especially its contribution to the sympathoexcitatory state found in HF, has not been broadly investigated. Therefore, questions about a possible association between the muscle receptors (mechano and metaboreceptors) in the genesis of the ergoreflex exacerbation, observed in HF, remain. Thus, the objective of this review was to integrate the knowledge on the mechano and metaboreflex (ergoreflex) in HF syndrome, as well as to clarify the influence of HF drug therapy on the ergoreflex.
authors.affiliation: Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil. jfcbelli@uol.com.br
authors.forename: Juliana Fernanda Canhadas
authors.initials: JF
authors.lastname: Belli
authors.forename: Fernando
authors.initials: F
authors.lastname: Bacal
authors.forename: Edimar Alcides
authors.initials: EA
authors.lastname: Bocchi
authors.forename: Guilherme Veiga
authors.initials: GV
authors.lastname: Guimarães
mesh_terms: D002628:Chemoreceptor Cells / Q000187:drug effects / Q000502:physiology; D017079:Exercise Tolerance / Q000502:physiology; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D018763:Muscle Fatigue / Q000502:physiology; D018482:Muscle, Skeletal / Q000294:innervation*; D010101:Oxygen Consumption / Q000502:physiology; D011311:Pressoreceptors / Q000187:drug effects / Q000503:physiopathology*; D012018:Reflex / Q000502:physiology*; D013577:Syndrome